Type 2 diabetes trials in Poland

In Poland 38 Also abroad 1200

38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Bialystok, Cracow, Lodz, Lublin, Poznan, Wrocław, Zabrze
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
Phase 3Taking people
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Where
Biała Podlaska, Bydgoszcz, Częstochowa, Gdansk, Gdynia, Katowice, Krakow, Lodz, Lublin, Poznan, Puławy, Siedlce, Staszów, Torun, Warsaw, Wroclaw
Age
18 years and over
People
1,560 worldwide
Run by
Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743450
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Where
Białystok, Lublin, Oswiecim, Warsaw, Zabrze
Age
18 years to 75 years
People
270 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00
Phase 3Taking people
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Where
Bialystok, Bydgoszcz, Cracow, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw, Warszawa
Age
18 years and over
People
1,010 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00
Phase 3Not yet taking people in Poland
Study of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
Where
Bialystok, Bydgoszcz, Cracow, Gdynia, Katowice, Lodz, Warsaw, Wroclaw, Wrocław
Age
18 years and over
People
760 worldwide
Run by
Tecnimede-Sociedade Tecnico-Medicinal S.A.
See details and how to join2025-524606-15-00 · EU 2025-524606-15-00
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Bialystok, Bolesławiec, Chorzów, Katowice, Libiąż, Lodz, Lublin, Olsztyn, Piotrkow Trybunalski, Poznan, Puławy, Rzeszow, Torun, Warsaw, Wroclaw, Zamość, Żyrardów
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Where
Bialystok, Częstochowa, Kielce, Krakow, Lodz, Lublin, Poznan, Radom, Warsaw
Age
18 years and over
People
2,150 worldwide
Run by
AstraZeneca
See details and how to joinNCT07606066
No phaseTaking people
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Where
Katowice
Age
1 year to 45 years
People
30,000 worldwide
Run by
INNODIA iVZW
See details and how to joinNCT07118098
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Where
Bialystok, Cracow, Częstochowa, Kielce, Lodz, Poznan, Radom, Warsaw
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Bialystok, Katowice, Lodz, Lublin, Oswiecim, Rzeszów, Swiecie, Szczecin, Tczew, Warsaw, Włocławek, Wroclaw, Zabrze
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
No phaseNot yet taking people in Poland
ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study
Where
Wroclaw
Age
18 years to 75 years
People
10,000
Run by
Jarosław Drobnik
See details and how to joinNCT07336563
No phaseTaking people
"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"
Where
Warsaw
Age
18 years and over
People
100
Run by
Medical University of Warsaw
See details and how to joinNCT07286500
No phaseEnrolling by invitation
Predictive Factors and Monitoring Strategies in Steroid-Induced Diabetes
Where
Warsaw
Age
18 years and over
People
250
Run by
Medical University of Warsaw
See details and how to joinNCT07190378